Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation (Q50775664)

19 March 2018

title

Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation (English)

1 reference

19 March 2018

main subject

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

1

1 reference

19 March 2018

author name string

U K Griffiths

2

1 reference

19 March 2018

M V Voeykova

3

1 reference

19 March 2018

O V Platonova

4

1 reference

19 March 2018

I L Shakhanina

5

1 reference

19 March 2018

G G Chistyakova

6

1 reference

19 March 2018

S E Robertson

7

1 reference

19 March 2018

Moscow Hib Study Team

8

1 reference

19 March 2018

language of work or name

English

0 references

publication date

15 December 2005

1 reference

19 March 2018

published in

Vaccine

1 reference

19 March 2018

volume

24

1 reference

19 March 2018

issue

13

1 reference

19 March 2018

page(s)

2367-2376

1 reference

19 March 2018

Childhood Haemophilus influenzae type b meningitis in Russia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Haemophilus influenzae type b conjugate vaccines: a review of efficacy data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Cost of treatment and prevention of Haemophilus influenzae type b disease. An international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Epidemiology of invasive Haemophilus influenzae disease in a German city

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Epidemiology of invasive Haemophilus influenzae type b infections among children in Greece before the introduction of immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Epidemiology of childhood bacterial meningitis in Poland. Incidence of bacterial meningitis with special reference to Haemophilus influenzae type b among children 0-59 months old in the former Kielce and Bydgoszcz districts in Poland in 1998-1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Incidence and etiological agents of bacterial meningitis among children <5 years of age in two districts of Romania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Risk of Haemophilus influenzae type b meningitis in Polish children varies directly with number of siblings: possible implications for vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Risk factors of invasive Haemophilus influenzae type b disease among children in Finland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Outcomes of bacterial meningitis in children: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Cost-benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Cost-benefit analysis of a Haemophilus influenzae type b meningitis prevention programme in The Philippines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Economic evaluation of Haemophilus influenzae type b vaccination in Slovenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.054

10.1016/J.VACCINE.2005.11.054

7 January 2021

Identifiers

DOI

1 reference

19 March 2018

release_ofgyqr7nqvhnpbhwxfqfdxvzie

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ofgyqr7nqvhnpbhwxfqfdxvzie

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

19 March 2018